Renaissance Technologies’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-97,269
Closed -$253K 4226
2023
Q2
$253K Buy
97,269
+50,269
+107% +$150K ﹤0.01% 3203
2023
Q1
$173K Sell
47,000
-7,000
-13% -$29.5K ﹤0.01% 3335
2022
Q4
$96K Buy
+54,000
New +$144K ﹤0.01% 3635
2022
Q3
Sell
-29,200
Closed -$162K 4510
2022
Q2
$162K Sell
29,200
-7,300
-20% -$59.8K ﹤0.01% 3725
2022
Q1
$536K Buy
+36,500
New +$488K ﹤0.01% 3146
2021
Q3
Sell
-63,300
Closed -$2.63M 3940
2021
Q2
$2.63M Sell
63,300
-100,300
-61% -$4.12M ﹤0.01% 2064
2021
Q1
$8.31M Buy
+163,600
New +$8.56M 0.01% 1315
2020
Q3
Sell
-14,400
Closed -$191K 3775
2020
Q2
$191K Buy
+14,400
New +$188K ﹤0.01% 3173

Other funds holding DMTK

Renaissance Technologies's DMTK Position: Q3 2023 in Review

Renaissance Technologies sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2023, closing a stake of 97,269 shares — an estimated $253K sold.

Renaissance Technologies first reported a position in DMTK in Q2 2020 and held it in 8 quarters. The position peaked at $8.31M in Q1 2021. 78 funds tracked by Wall St. Rank hold DMTK as of Q3 2023.

  • Renaissance Technologies reported no remaining DermTech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 97,269 DermTech, Inc. Common Stock shares in Q3 2023, an estimated $253K.
  • Renaissance Technologies first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Renaissance Technologies's DermTech, Inc. Common Stock position peaked at $8.31M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.